Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in...

FDA Recall #D-0656-2020 — Class I — December 17, 2019

Recall #D-0656-2020 Date: December 17, 2019 Classification: Class I Status: Terminated

Product Description

Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX

Reason for Recall

Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

Recalling Firm

Motto International Corp — Dallas, TX

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

5 boxes

Distribution

TX

Code Information

All lots remaining within expiry.

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls